library Email this page members only
about uscib global network what's new
    Search      
Home Policy Advocacy: USCIB Committees and Working Groups Dispute Resolution: USCIB and ICC Arbitration Calendar of Events: USCIB and Partner Events Trade Services: USCIB Services to Facilitate U.S. Exports/Imports ATA Carnet: USCIB's Duty-Free and Tax-Free Temporary Exports/Imports
USCIB

Committee Officers

Arbitration

Banking

Biotechnology

China

Competition

Corporate Responsibility

Customs & Trade Facilitation

Emerging Markets

Energy

Environment

European Union

Financial Services

Food & Agriculture

Health Care

Information, Communications & Technology

Intellectual Property

Labor & Employment

Manhattan India Investment Roundtable

Marketing & Advertising

Nanotechnology

Product Policy

Taxation

Trade and Investment

Transportation

contact us
membership info
membership info

Committee Profile

Nanotechnology

 

Background

Nanotechnology -- the engineering of functional systems at the molecular scale -- is emerging as a transformative and core foundation for economic growth and development in the 21st Century.  Applications are proliferating as rapid advances in the underlying science and technology intersect with significant new markets and business opportunities across multiple sectors. Potential nanotechnology-related markets around the world have been forecast to reach $1 trillion by 2015, and nanotechnology will likely play a leading role in more than 15 major business sectors, ranging from the life sciences, electronics, energy and chemicals to consumer products, textiles and cosmetics.

The complexity and dynamism of nanotechnology make it imperative that governments get the policy framework “right” to realize its enormous economic, technological and societal promise.

 

Objectives

Advocate science-based effective and proportionate sectoral regulation to protect human and environmental health and safety, while enabling innovative research, development and commercialization to realize nanotechnology’s societal and economic benefits. Promote international coordination to facilitate globalizing R&D and value chain operations. Contribute to enhanced public understanding of nanotechnology’s enormous potential for innovative and transformative products to address current problems.

 

 

 

 

 

 

Co-Chairs

 

Terry Medley

Global Director, Corporate Regulatory Affairs

E.I. du Pont de Nemours & Co.

 

Richard A. Johnson

Partner

Arnold & Porter, LLP

 

Staff Contacts

 

Helen Medina

Director – Life Sciences and Product Policy

(212) 703-5047

hmedina@uscib.org 

 

Kira Yevtukhova

Program Assistant

(212) 703-5082

kyevtukhova@uscib.org

 

Current Priorities

·         Through BIAC, provide industry leadership on key OECD nanotechnology policy and regulatory activities:

-  Addressing environmental and human health and safety (EHS) issues in eight projects under the
   Working Party on Manufactured Nanomaterials.

-  Promoting an enabling regulatory framework for nanotechnology innovation and commercialization  
   through participating in the Working Party on Nanotechnology.

-  Providing industry expertise on the potential for nanotechnology to meet global challenges in areas
   such as water, health and environment.

 

·         Utilize the BIAC Expert Group on Nanotechnology to provide consensus input to the International Forum on Chemical Safety’s nanotechnology discussion at Forum VI, which is the sixth session of the Intergovernmental Forum on Chemical Safety (IFCS) taking place in Dakar.

 

Recent Accomplishments

·          Organized meeting between US industry and US government officials to discuss and provide US business input to issues related to nanotechnology.

·         Contributed U.S. business views to the BIAC statement on the IFCS draft Thought Starter.

 





ALL RIGHTS RESERVED 2013 | PRIVACY POLICY STATEMENT | CONTACT US